Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
SEVOFLURANE SANDOZ (Sandoz Pty Ltd)
Product name
SEVOFLURANE SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
145 working days (255)
Active ingredients
sevoflurane
Registration type
New generic medicine
Indication
SEVOFLURANE SANDOZ (solution for inhalation) may be used for induction and maintenance of general anaesthesia in adult and paediatric patients undergoing surgery.